ArticleTherapeutic advances in neurological disorders2025
Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label study.
Jan Kassubek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.